Literature DB >> 4029717

Intravenous omeprazole rapidly raises intragastric pH.

R P Walt, J R Reynolds, M J Langman, H L Smart, G Kitchingman, K W Somerville, C J Hawkey.   

Abstract

Twenty four hour intragastric acidity was measured in five duodenal ulcer patients studied at least three times. The effects of different dosage regimens of intravenous omeprazole was compared with placebo. Mean intragastric acidity from 1000 to 0800 was 34.3 +/- 4.3 mmol/l on placebo. After omeprazole 80 mg at 0900 and 40 mg at 1700 mean acidity was 2.1 +/- 0.9 mmol/l and after omeprazole 80 mg at 0900 and 80 mg at 1700 it was 0.7 +/- 0.2 mmol/l. pH remained above 4.0 for about 80% of recordings with these regimens and for only 5% with placebo. Three of the five patients also received omeprazole 80 mg at 0900, 40 mg at 1700 and 40 mg at 0100 when pH remained above 4.0 for 90% of recordings with 99% inhibition of acidity. Omeprazole rapidly raised intragastric pH in all patients and maintained a gastric pH of greater than 4.0 for most of the time. Large doses of IV omeprazole were required compared with studies using the oral compound.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029717      PMCID: PMC1432870          DOI: 10.1136/gut.26.9.902

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  A nonelectrogenic H+ pump in plasma membranes of hog stomach.

Authors:  G Sachs; H H Chang; E Rabon; R Schackman; M Lewin; G Saccomani
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

2.  Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.

Authors:  B Wallmark; G Sachs; S Mardh; E Fellenius
Journal:  Biochim Biophys Acta       Date:  1983-02-09

3.  Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.

Authors:  L Olbe; U Haglund; R Leth; T Lind; C Cederberg; G Ekenved; B Elander; E Fellenius; P Lundborg; B Wallmark
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

4.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

5.  24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

6.  Effect of daily oral omeprazole on 24 hour intragastric acidity.

Authors:  R P Walt; M D Gomes; E C Wood; L H Logan; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02
  6 in total
  14 in total

1.  Omeprazole for acute upper gastrointestinal bleeding.

Authors:  J H Baron
Journal:  BMJ       Date:  1992-02-08

2.  Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

Authors:  M J Levy; C B Seelig; N J Robinson; J E Ranney
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.

Authors:  J B Jansen; P Lundborg; L C Baak; J Greve; M Ohman; C Stöver; K Röhss; C B Lamers
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

4.  Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids.

Authors:  L C Baak; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

5.  Twenty four hour intragastric acidity analysis for the future.

Authors:  R Walt
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

6.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

7.  Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.

Authors:  S Teyssen; S T Chari; J Scheid; M V Singer
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Individual and group dose-responses to intravenous omeprazole in the first 24 h: pH-feedback-controlled and fixed-dose infusions.

Authors:  C H Wilder-Smith; H U Bettschen; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 9.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

Review 10.  Current management of bleeding peptic ulcer. A review.

Authors:  M Z Panos; R P Walt
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.